Literature DB >> 6017171

Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.

M H Gault, M W Cohen, L M Kahana, F T Leelin, J F Meakins, M Aronovitch.   

Abstract

Serial determinations of serum lactic-acid dehydrogenase (LDH), phosphohexose isomerase (PHI), alkaline phosphatase (AP), and glutamic oxaloacetic transaminase (GOT) were carried out in 30 patients with primary and four with secondary neoplasms of the lung. Enzyme values were correlated with the stage of illness, with tumour histology, with chemotherapy and with the extent and site of metastases as determined at autopsy. The activity of the enzymes LDH and PHI was most frequently elevated; their values correlated closely. AP and GOT tended to become elevated only shortly before death. Although, in general, enzyme activity increased with tumour extension and often in relation to chemotherapy, assays provided little assistance in early diagnosis or prognosis except that, in most instances, elevated values of any of the four enzymes indicated the presence of metastases.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6017171      PMCID: PMC1935913     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  27 in total

1.  SERUM PHOSPHOHEXOSEISOMERASE FRACTIONS IN PATIENTS TREATED WITH CANCER CHEMOTHERAPY.

Authors:  S WINSTEN; S LEVICK; E COHN
Journal:  Cancer       Date:  1965-09       Impact factor: 6.860

2.  The clinical significance of alterations in lactic dehydrogenase activity of body fluids.

Authors:  F WROBLEWSKI
Journal:  Am J Med Sci       Date:  1957-09       Impact factor: 2.378

3.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.

Authors:  S REITMAN; S FRANKEL
Journal:  Am J Clin Pathol       Date:  1957-07       Impact factor: 2.493

4.  Lactic dehydrogenase activity in human serum.

Authors:  H G WEINSTEIN; H J ZIMMERMAN
Journal:  J Lab Clin Med       Date:  1956-10

5.  Comparison of phosphohexose isomerase and lactic dehydrogenase activities in plasma, liver, and tumor tissue of tumor-bearing rats.

Authors:  O BODANSKY; J SCHOLLER
Journal:  Cancer Res       Date:  1956-10       Impact factor: 12.701

6.  Some biochemical characteristics of morphologically separable cancers.

Authors:  J P GREENSTEIN
Journal:  Cancer Res       Date:  1956-08       Impact factor: 12.701

7.  Serum lactic dehydrogenase activity as indication of neoplastic growth and regression.

Authors:  K M HSIEH; V SUNTZEFF; E V COWDRY
Journal:  Proc Soc Exp Biol Med       Date:  1955-08

8.  Serum phosphohexose isomerase in cancer. I. Method of determination and establishment of range of normal values.

Authors:  O BODANSKY
Journal:  Cancer       Date:  1954-11       Impact factor: 6.860

9.  Alterations of serum lactate dehydrogenase isoenzymes during therapy directed at lung cancer.

Authors:  W H Starkweather; R A Green; H H Spencer; H K Schoch
Journal:  J Lab Clin Med       Date:  1966-08

10.  Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast.

Authors:  O BODANSKY
Journal:  Cancer       Date:  1954-11       Impact factor: 6.860

View more
  2 in total

1.  Serum enzyme changes after major lung surgery--with and without halothane.

Authors:  A R Hunter
Journal:  Thorax       Date:  1968-07       Impact factor: 9.139

2.  Pancreatic alkaline phosphatase and a tumour variant.

Authors:  T W Warnes; W R Timperley; P Hine; G Kay
Journal:  Gut       Date:  1972-07       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.